These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11382567)

  • 1. Glucocorticoid therapy and diabetes management.
    Volgi JR; Baldwin D
    Nurs Clin North Am; 2001 Jun; 36(2):333-9, viii. PubMed ID: 11382567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New methods of management in diabetes].
    Mocochain A; Pichavant P
    Rev Infirm; 2003 Jun; (92):23-4. PubMed ID: 14560452
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic issues in oral glucocorticoid use.
    Bello CE; Garrett SD
    Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy].
    Meyer G; Badenhoop K
    Med Klin (Munich); 2003 Apr; 98(5):266-70. PubMed ID: 12721671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorder of glucose metabolism regulation in patients with multiple myeloma treated with high doses of corticosteroids at our clinic in 2004].
    Pospísilová Y; Adam Z
    Vnitr Lek; 2007 Jan; 53(1):18-23. PubMed ID: 17472011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control.
    Tan MY; Magarey J
    Patient Educ Couns; 2008 Aug; 72(2):252-67. PubMed ID: 18467068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of insulin pumps for diabetes management.
    Webb KE
    Medsurg Nurs; 2006 Apr; 15(2):61-8, 94; quiz 69. PubMed ID: 16700243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing diabetes mellitus in patients with multiple myeloma.
    Chou YS; Yang CF; Chen HS; Yang SH; Yu YB; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH; Hsiao LT
    Eur J Haematol; 2012 Oct; 89(4):320-7. PubMed ID: 22758386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
    Jacobson PB; von Geldern TW; Ohman L; Osterland M; Wang J; Zinker B; Wilcox D; Nguyen PT; Mika A; Fung S; Fey T; Goos-Nilsson A; Grynfarb M; Barkhem T; Marsh K; Beno DW; Nga-Nguyen B; Kym PR; Link JT; Tu N; Edgerton DS; Cherrington A; Efendic S; Lane BC; Opgenorth TJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):191-200. PubMed ID: 15784656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Self monitoring using a capillary glycemia measurement. Diabetes mellitus, type 2].
    Llamas Urrutia C; Ares Carceller C; Hernández Figols E
    Rev Enferm; 1996 Sep; 19(217):17-20. PubMed ID: 8945382
    [No Abstract]   [Full Text] [Related]  

  • 15. [Orally treated type 2 diabetic patients: blood glucose self monitoring useless?].
    Einecke D
    MMW Fortschr Med; 2008 May; 150(18):6; discussion 7. PubMed ID: 18533599
    [No Abstract]   [Full Text] [Related]  

  • 16. Self-monitoring of blood glucose in diabetes: is it worth it?
    O'Kane MJ; Pickup J
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):273-82. PubMed ID: 19454538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract]   [Full Text] [Related]  

  • 18. Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes.
    Mao XM; Liu H; Tao XJ; Yin GP; Li Q; Wang SK
    Diabetes Metab Res Rev; 2009 Jul; 25(5):435-41. PubMed ID: 19405039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management.
    Kruger DF
    J Am Acad Nurse Pract; 2008 Nov; 20 Suppl 1():17-20. PubMed ID: 19402256
    [No Abstract]   [Full Text] [Related]  

  • 20. STOP-NIDDM: a new paradigm for diabetes prevention?
    Hanefeld M
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):253-8. PubMed ID: 12616804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.